Lifecare AS Total Liabilities

Latest as of June 2026: Nkr8.48 Million NOK ≈ $892.02K USD

Lifecare AS total liabilities. Based on the latest financial reports, Lifecare AS (LIFE) has total liabilities worth Nkr8.48 Million NOK (≈ $892.02K USD) as of June 2026. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Check financial resilience of Lifecare AS to evaluate the company's liquid asset resilience ratio.

Total Liabilities of Lifecare AS (2015–2025)

Total liabilities of Lifecare AS from 2015 to 2025. This chart illustrates how Lifecare AS's total liabilities have evolved over time, based on quarterly financial data.

Lifecare AS Competitors by Total Liabilities

The table below lists competitors of Lifecare AS ranked by their total liabilities.

Company Country Total Liabilities
Doosan Solus Co Ltd Pref 1P
KO:33637K
Korea ₩1.20 Trillion
Silvair Inc
WAR:SVRS
Poland zł6.92 Million
SAMJIN Co. Ltd
KQ:032750
Korea ₩15.24 Billion
Tobii AB
ST:TOBII
Sweden Skr813.00 Million
Rubberex Corporation M Bhd
KLSE:7803
Malaysia RM31.72 Million
Hansol Homedec
KO:025750
Korea ₩130.01 Billion
Hua Yang Bhd
KLSE:5062
Malaysia RM374.52 Million
Esotiq & Henderson S.A.
WAR:EAH
Poland zł135.06 Million

Liability Composition Analysis (2015–2025)

This chart breaks down Lifecare AS's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the complete balance sheet picture, see LIFE total assets.

Liquidity & Leverage Metrics

Lifecare AS Total Liabilities Ratios Explained

Lifecare AS total liabilities ratios compare its liabilities with its current assets, cash and shareholder equity.

Metric Value Description
Current Ratio 11.69 Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio N/A More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio N/A Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity 0.15 Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets 0.13 Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how Lifecare AS's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for Lifecare AS (2015–2025)

The table below shows the annual total liabilities of Lifecare AS from 2015 to 2025.

Year Total Liabilities Change
2025-12-31 Nkr122.67 Million
≈ $12.91 Million
+217.65%
2024-12-31 Nkr38.62 Million
≈ $4.06 Million
+93.71%
2023-12-31 Nkr19.94 Million
≈ $2.10 Million
+35.40%
2022-12-31 Nkr14.72 Million
≈ $1.55 Million
+84.57%
2021-12-31 Nkr7.98 Million
≈ $839.42K
+521.48%
2020-12-31 Nkr1.28 Million
≈ $135.07K
-27.16%
2019-12-31 Nkr1.76 Million
≈ $185.43K
+49.43%
2018-12-31 Nkr1.18 Million
≈ $124.09K
-66.70%
2017-12-31 Nkr3.54 Million
≈ $372.62K
+250.04%
2016-12-31 Nkr1.01 Million
≈ $106.45K
+71.51%
2015-12-31 Nkr589.82K
≈ $62.07K
--

About Lifecare AS

OL:LIFE Norway Medical Devices
Market Cap
$16.60 Million
Nkr157.78 Million NOK
Market Cap Rank
#25522 Global
#238 in Norway
Share Price
Nkr0.39
Change (1 day)
-6.86%
52-Week Range
Nkr0.28 - Nkr5.86
All Time High
Nkr95.08
About

Lifecare ASA, together with its subsidiaries, operates as a medical sensor company that develops technology for sensing and monitoring of various body analytes in Norway and United Kingdom. The company develops Sencell, a 3D printed nano-sensor for monitoring glucose levels in patients with diabetes and for veterinary applications; as well as medical devices that remove subdermal implants. Lifeca… Read more